Guangxu Lan

Guangxu Lan

Auto-generated profile, based on publicly available information

Guangxu Lan

Beijing National Laboratory for Molecular Science, State Key Laboratory of Rare Earth Materials Chemistry and Applications, College of Chemistry and Molecular Engineering

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2018 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
GLGuangxu Lan
Guangxu Lan
KNKaiyuan Ni
Kaiyuan Ni
ZXZiwan Xu
Ziwan Xu
SVSamuel S. Veroneau
Samuel S. Veroneau
YSYang Song
Yang Song
WLWenbin Lin
Wenbin Lin

26 March 2018 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
KLKuangda Lu
Kuangda Lu
CHChunbai He
Chunbai He
NGNining Guo
Nining Guo
CCChristina Chan
Christina Chan
KNKaiyuan Ni
Kaiyuan Ni
WLWenbin Lin
Wenbin Lin

21 October 2017 in Coordination Chemistry Reviews
Verified
Journal Article
Closed access
GLGuangxu Lan
Guangxu Lan
KNKaiyuan Ni
Kaiyuan Ni
WLWenbin Lin
Wenbin Lin

15 June 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
KNKaiyuan Ni
Kaiyuan Ni
GLGuangxu Lan
Guangxu Lan
CCChristina Chan
Christina Chan
BQBryan Quigley
Bryan Quigley
KLKuangda Lu
Kuangda Lu
WLWenbin Lin
Wenbin Lin
Checkpoint blockade immunotherapy enhances systemic antitumor immune response by targeting T cell inhibitory pathways; however, inadequate T cell infiltration has limited its anticancer efficacy. Radiotherapy (RT) has local immunomodulatory effects that can alter the microenvironment of irradiated tumors to synergize with immune checkpoint blockade. However, even with high doses of radiation, RT has rarely elicited systemic immune responses. Herein, we report the design of two porous Hf-based nanoscale metal-organic frameworks (nMOFs) as highly effective radioenhancers that significantly outperform HfO2, a clinically investigated radioenhancer in vitro and in vivo. Importantly, the combination of nMOF-mediated low-dose RT with an anti-programmed death-ligand 1 antibody effectively extends the local therapeutic effects of RT to distant tumors via abscopal effects. Our work establishes the feasibility of combining nMOF-mediated RT with immune checkpoint blockade to elicit systemic antitumor immunity in non-T cell-inflamed tumor phenotypes without normal tissue toxicity, promising to broaden the application of checkpoint blockade immunotherapy.

17 October 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
KNKaiyuan Ni
Kaiyuan Ni
GLGuangxu Lan
Guangxu Lan
SVSamuel S. Veroneau
Samuel S. Veroneau
XDXiaopin Duan
Xiaopin Duan
YSYang Song
Yang Song
WLWenbin Lin
Wenbin Lin
Selective delivery of photosensitizers to mitochondria of cancer cells can enhance the efficacy of photodynamic therapy (PDT). Though cationic Ru-based photosensitizers accumulate in mitochondria, they require excitation with less penetrating short-wavelength photons, limiting their application in PDT. We recently discovered X-ray based cancer therapy by nanoscale metal–organic frameworks (nMOFs) via enhancing radiotherapy (RT) and enabling radiodynamic therapy (RDT). Herein we report Hf-DBB-Ru as a mitochondria-targeted nMOF for RT-RDT. Constructed from Ru-based photosensitizers, the cationic framework exhibits strong mitochondria-targeting property. Upon X-ray irradiation, Hf-DBB-Ru efficiently generates hydroxyl radicals from the Hf6 SBUs and singlet oxygen from the DBB-Ru photosensitizers to lead to RT-RDT effects. Mitochondria-targeted RT-RDT depolarizes the mitochondrial membrane to initiate apoptosis of cancer cells, leading to significant regression of colorectal tumors in mouse models. Our work establishes an effective strategy to selectively target mitochondria with cationic nMOFs for enhanced cancer therapy via RT-RDT with low doses of deeply penetrating X-rays.

19 February 2019 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
GLGuangxu Lan
Guangxu Lan
KNKaiyuan Ni
Kaiyuan Ni
SVSamuel S. Veroneau
Samuel S. Veroneau
XFXuanyu Feng
Xuanyu Feng
GNGeoffrey T. Nash
Geoffrey T. Nash
WLWenbin Lin
Wenbin Lin